T Oku

662 total citations
19 papers, 554 citations indexed

About

T Oku is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, T Oku has authored 19 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in T Oku's work include Cytokine Signaling Pathways and Interactions (7 papers), Immune Cell Function and Interaction (4 papers) and Inflammatory mediators and NSAID effects (3 papers). T Oku is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Immune Cell Function and Interaction (4 papers) and Inflammatory mediators and NSAID effects (3 papers). T Oku collaborates with scholars based in Japan and Australia. T Oku's co-authors include Ryotaro Yoshida, Jirô Imanishi, Tsunataro Kíshida, O Hayaishi, Osamu Takikawa, Shinichi Nakamura, Hisahiro Yoshida, Katsuhisa Nakata, Shin‐ichi Muramatsu and Satoshi Shimizu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

T Oku

19 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Oku Japan 12 229 198 132 93 92 19 554
Mark Du United States 7 361 1.6× 363 1.8× 199 1.5× 111 1.2× 152 1.7× 8 798
Egle Šimelyte Finland 11 239 1.0× 69 0.3× 163 1.2× 90 1.0× 41 0.4× 15 563
Christian Hucke Germany 8 142 0.6× 155 0.8× 73 0.6× 69 0.7× 79 0.9× 10 428
Susana A. Serrate United States 8 299 1.3× 27 0.1× 177 1.3× 82 0.9× 57 0.6× 12 656
Silvia Silla Italy 10 413 1.8× 93 0.5× 103 0.8× 51 0.5× 39 0.4× 13 508
Joy Ogbechi United Kingdom 11 115 0.5× 151 0.8× 156 1.2× 30 0.3× 92 1.0× 15 525
Nan-Sun Kim South Korea 15 199 0.9× 92 0.5× 386 2.9× 70 0.8× 30 0.3× 24 655
Besma Bel Hadj Jrad Tunisia 13 133 0.6× 59 0.3× 203 1.5× 82 0.9× 23 0.3× 36 488
Kristy M. Greeneltch United States 10 220 1.0× 25 0.1× 115 0.9× 121 1.3× 39 0.4× 14 428
Karine R. Mayilyan Armenia 8 227 1.0× 102 0.5× 82 0.6× 14 0.2× 32 0.3× 12 396

Countries citing papers authored by T Oku

Since Specialization
Citations

This map shows the geographic impact of T Oku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Oku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Oku more than expected).

Fields of papers citing papers by T Oku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Oku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Oku. The network helps show where T Oku may publish in the future.

Co-authorship network of co-authors of T Oku

This figure shows the co-authorship network connecting the top 25 collaborators of T Oku. A scholar is included among the top collaborators of T Oku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Oku. T Oku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yoshida, Ryotaro, et al.. (2000). Leukocyte Integrin‐Dependent and Antibody‐Independent Cytotoxicity of Macrophage against Allografts. Microbiology and Immunology. 44(1). 57–67. 18 indexed citations
2.
Hase, Koji, T Oku, Fumitomo Koizumi, et al.. (1998). Effect of Spikelets ofMiscanthus sinensison IgE-Mediated Biphasic Cutaneous Reaction in Mice. Planta Medica. 64(1). 12–17. 4 indexed citations
3.
Takikawa, Osamu, T Oku, Naoto Ito, et al.. (1996). Multiple Expression of Ly-6C and Accumulation of a Ly-6C Pre-mRNA in Activated Macrophages Involved in Rejection of an Allografted Tumor. Biochemical and Biophysical Research Communications. 226(1). 247–253. 16 indexed citations
4.
Yasui, Hiroaki, Osamu Takikawa, T Oku, & Ryotaro Yoshida. (1994). Induction in Interferon-α/β-Treated Hepatocytes of the Inhibitor of the Multiplication of IFN-α/β-Resistant Friend Leukemia Cells. Journal of Interferon Research. 14(5). 245–250. 1 indexed citations
5.
Takikawa, Osamu, T Oku, Hiroaki Yasui, & Ryotaro Yoshida. (1993). Synergism between IFN-gamma and IL-1 alpha/beta in growth inhibition of an allografted tumor.. The Journal of Immunology. 151(4). 2070–2076. 18 indexed citations
6.
Yoshida, Ryotaro, et al.. (1991). Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice.. Proceedings of the National Academy of Sciences. 88(4). 1526–1530. 37 indexed citations
7.
Nakata, Katsuhisa, et al.. (1988). Augmented antitumor effect of recombinant human interleukin-1 alpha by indomethacin.. PubMed. 48(3). 584–8. 50 indexed citations
8.
Yoshida, Ryotaro, et al.. (1986). Interferon: A mediator of indoleamine 2,3-dioxygenase induction by lipopolysaccharide, poly(I) · poly(C), and pokeweed mitogen in mouse lung. Archives of Biochemistry and Biophysics. 249(2). 596–604. 44 indexed citations
9.
Oku, T, Jirô Imanishi, & Tsunataro Kíshida. (1986). Antiviral effect of two aryl-oligopeptides, FR41565 and FR48217. Antiviral Research. 6(4). 233–239. 7 indexed citations
10.
Uno, Kazuko, et al.. (1985). Direct and indirect effects of interferon on in vivo murine tumor cell growth.. PubMed. 45(3). 1320–7. 45 indexed citations
11.
Oku, T, Jirô Imanishi, & Tsunataro Kíshida. (1984). Interferon counteracts pyrimidinone-induced hyporeactivity and the combined treatment has antitumor effect in mice.. PubMed. 75(7). 631–40. 5 indexed citations
12.
Tomida, Mikio, Yuri Yamamoto-Yamaguchi, Motoo Hozumi, T Oku, & Tsunataro Kíshida. (1983). Prolongation by interferon preparation of the survival time of mice implanted with differentiation-inducible mouse myeloid leukemia cells. Leukemia Research. 7(3). 439–441. 4 indexed citations
13.
Imanishi, Jirô, Masakazu Kita, Shigeru Sugino, T Oku, & Tsunataro Kíshida. (1982). Elimination of Polynucleotide-Induced Hyporeactivity in Mice Treated with Interferon and Antitumor Therapy. Journal of Interferon Research. 2(1). 65–74. 1 indexed citations
14.
Tanaka, Takao, et al.. (1982). Effects of interferon on C1300 mouse neuroblastoma.. PubMed. 66(7). 1575–7. 6 indexed citations
15.
Tsuruo, T, et al.. (1982). Different susceptibilities of cultured mouse cell lines to mouse interferon.. PubMed. 73(1). 42–7. 11 indexed citations
16.
Oku, T, Jirô Imanishi, & Tsunataro Kíshida. (1982). Assessment of anti-tumor cell effect of human leukocyte interferon in combination with anticancer agents by a convenient assay system in monolayer cell culture.. PubMed. 73(4). 667–74. 11 indexed citations
17.
Yoshida, Ryotaro, Jirô Imanishi, T Oku, Tsunataro Kíshida, & O Hayaishi. (1981). Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.. Proceedings of the National Academy of Sciences. 78(1). 129–132. 228 indexed citations
18.
Imanishi, Jirô, et al.. (1981). New simple dye-uptake assay for interferon.. PubMed. 24(3). 103–8. 13 indexed citations
19.
Yoshida, Ryotaro, et al.. (1981). Inhibition of interferon-mediated induction of indoleamine 2,3-dioxygenase in mouse lung by inhibitors of prostaglandin biosynthesis.. Proceedings of the National Academy of Sciences. 78(12). 7327–7330. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026